Generic Drugs Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue



A generic drug is a pharmaceutical product that is generally intended to be interchangeable with an innovator or a branded drug. Generics are manufactured without a licence from the innovator company and are identical or bio-equivalent to an innovator drug in dosage form, safety, strength, route of administration, quality, performance characteristics and intended use. Generic drugs are launched and marketed after the expiry date of the patent or other exclusive rights. Although generic drugs are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments. Since the drug’s formula is known, the clinical trials are complete; the generic drug manufacturer’s only requirement is to demonstrate to the regulators that its version is as good and effective as the innovator or branded drug.

According to the IMARC Group, the global generic drugs market was valued at around US$ 330 Billion in 2015, growing at a CAGR of around 10% during 2010-2015. The biggest catalyst for growth is an increasing global pharmaceutical spending trend towards generics. Continuously increasing healthcare expenditures have pushed governments and third-party payers to seek ways to control their healthcare expenditures. This is catalyzing an increasing demand for generics versus their branded counterparts. Another major driver of this industry is the continued patent cliff that is providing growing pipelines opportunities for generic firms. Similarly, a growth in the overall global population and aging demographics is also proving to be beneficial for the overall healthcare sector including generic drug manufacturers. Healthcare reforms in the US and other developed markets coupled with strong growth in emerging market are some other important drivers for the generic drugs market.

IMARC’s latest study “Generic Drugs Market - Industry Trends, Manufacturing Process, Plant Setup, Machinery, Raw Materials, Cost and Revenue” provides a comprehensive roadmap for stakeholders who are planning to setup and run a generic drugs manufacturing plant. The study covers all the requisite aspects of the generic drugs market. This ranges from macro overview of the market, industry performance, processing and manufacturing requirements, project cost, project funding, project economics, expected returns on investment, profit margins, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who are planning to foray into the generic drugs market in any manner.

 

Key Questions Answered in This Report?

  • What are the historical, current and future trends in the generic drugs market?
  • Which are the world’s biggest markets for generic drugs?
  • What is the competitive structure of the generic market and who are the key players?
  • What is the value chain of generic drugs?
  • What are the key success factors for generic drug manufacturers?
  • What are the regulations in the generic market?
  • How are generic drugs manufactured?
  • What are the raw material requirements and their cost for manufacturing generic drugs?
  • What are the land and construction requirements and their cost for manufacturing generic drugs?
  • What are the machinery requirements and their cost for manufacturing generic drugs?
  • What are the packaging requirements and their cost for manufacturing generic drugs?
  • What are the utility requirements and their cost for manufacturing generic drugs?
  • What are the manpower requirements and their cost for manufacturing generic drugs?
  • What is the total capital investment required for setting up a generic drug manufacturing plant?
  • What are the operational costs for setting up a generic drugs manufacturing plant?
  • How much income will the generic drugs manufacturing plant generate?
  • What will be the profitability of the generic drugs manufacturing plant?
  • What will be the NPV of the generic drugs manufacturing plant?
  • What will be the payback period of the generic drugs manufacturing plant?                                       

1 Research Methodology
2 Executive Summary
3 Introduction
4 Global Generic Drugs Industry Analysis

    4.1 Classification of Generic Drugs
    4.2 Market Trends
        4.2.1 Current and Historical Market Trends
        4.2.2 Market Breakup by Region
        4.2.3 Competitive Structure and Major Players in the Generic Drug Industry
        4.2.4 Market Forecast
    4.3 Value Chain Analysis of Generic Drugs
    4.4 Key Success Factors for Generic Manufacturers
    4.6 Regulations in the Generic Industry
5 Manufacturing Process of Generic Drugs
    5.1 Detailed Process Flow
    5.2 Generic Drugs Manufacturing Plant: Raw Material Requirements
6 Project Details, Requirements and Costs Involved
    6.1 Land, Location and Site Development
    6.2 Plant Layout
    6.3 Plant Machinery
    6.4 Machinery Pictures
    6.5 Raw Materials
    6.6 Packaging
    6.7 Utilities
    6.8 Manpower
    6.9 Other Capital Investments
7 Project Economics
    7.1 Capital Cost of the Project
    7.2 Loans and Financial Assistance
    7.3 Techno-Economic Parameters
    7.4 Product Pricing
    7.5 Income Projections
    7.6 Expenditure Projections
    7.7 Financial Analysis

 

List of Figures

Figure 4 1: Global: Generic Drugs Market: Sales Value (in US$ Billion), 2011-2015
Figure 4 2: Global: Generic Drugs Market: Breakup by Country (in %), 2015
Figure 4 3: Global: Generic Drugs Market Forecast: Sales Value (in US$ Billion), 2015-2020
Figure 4 4: Global: Generic Drugs Market: Value Chain
Figure 6 1: Generic Drug Manufacturing: Detailed Process Flow and Various Types of Unit Operations Involved
Figure 6 2: Generic Drug Manufacturing Process: Conversion Rate of Feedstocks
Figure 7 1: Generic Drug Manufacturing Plant: Proposed Plant Layout
Figure 7 2: Generic Drug Manufacturing Plant: Primary Packaging
Figure 7 3: Generic Drug Manufacturing Plant: Secondary Packaging
Figure 7 4: Generic Drug Manufacturing Plant: Tertiary Packaging
Figure 8 1: Generic Drug Manufacturing Plant: Breakup of Capital Costs (in %)
Figure 8 2: Generic Drug Manufacturing Plant: Breakup of Production Costs (in %)

 

List of Tables

Table 4 1: Global: Generic Drugs Market: Revenues of Key Players (in US$ Billion), 2015
Table 7 1: Generic Drug Manufacturing Costs Related to Land and Site Development (in US$)
Table 7 2: Generic Drug Manufacturing Costs Related to Civil Works (in US$)
Table 7 3: Machinery Costs (in US$)
Table 7 4: Raw Material Requirements (in Kg/Day)
Table 7 5: Costs Related to Salaries and Wages (in US$)
Table 7 6: Costs Related to Other Capital Investments
Table 8 1: Capital Costs (in US$)
Table 8 2: Details of Financial Assistance Offered by Financial Institutions
Table 8 3: Loan Installments
Table 8 4: Techno- Economic Parameters
Table 8 5: Income Projections (in US$)
Table 8 6: Expenditure Projections (in US$)
Table 8 7: Cash Flow Analysis Without Considering the Income Tax Liability
Table 8 8: Cash Flow Analysis on Considering the Income Tax Liability


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.






Related Report

Global Biopharmaceutical Manufacturing Market Report 2016-2021

IMARC Group’s latest report titled “Global Biopharmaceutical Manufacturing Market Report 2016-2021” provides a detailed analysis on the global biopharmaceutical manufacturing industry. Biopharmaceuticals represent one of the most elegant and sophisticated achievements of modern science. Compar...


Global Biopharmaceutical Market Report & Forecast (2016-2021)

IMARC’s new report “Global Biopharmaceutical Market Report & Forecast (2016-2021)” gives a deep insight into the global biopharmaceutical market. The research study serves as an analytical as well as a statistical tool to understand the strengths, weaknesses, opportunities, threats, market tre...


Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2016-2021)

The new report from IMARC group entitled ‘Global Portable Medical and Healthcare Devices Market Report (Cardiac Monitoring Devices, Blood Glucose Monitoring, Pulse Oximetry Devices, Wearable BP Monitors, Smart Wrist-Wearables, Smart Garments etc.) (2008-2021)’ maps out a comprehensive analysis o...


Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Canada Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand...


Japan Generic Drug Market - Industry Trends, Competitive Landscape, Opportunities and Outlook

The report entitled “Japan Generic Drug Market: Industry Trends, Competitive Landscape, Opportunities and Outlook” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Japan. This research report serves as an exceptional tool to understand th...